Form 4 for XENE Xenon Pharmaceuticals Inc.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-22 · accession 0000950170-24-130378 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-11-22 | 2024-11-22 | XENE | PATOU GARY | Dir | M - OptEx | $10.24 | +6,586 | 26.7K | +33% | +$67.4K |
| DM | 2024-11-22 | 2024-11-22 | XENE | PATOU GARY | Dir | F - Tax | $39.80 | -1,695 | 25.6K | -6% | -$67.5K |
| DM | 2024-11-22 | 2024-11-22 | XENE | PATOU GARY | Dir | S - Sale+OE | $41.08 | -4,891 | 23.6K | -17% | -$200.9K |
| DM | 2024-11-22 | 2024-11-22 | XENE | PATOU GARY | Dir | M - OptEx | $0.00 | -6,586 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-11-22 | M | A | 3,500 | $7.38 | 27,073 | D | — | — | |
| 2 | Common | Common Shares | 2024-11-22 | F | D | 649 | $39.80 | 26,424 | D | — | — | (F1) Represents the closing price of the Company's common shares on November 21, 2024 for purposes of net settlement calculations. |
| 3 | Common | Common Shares | 2024-11-22 | S | D | 2,040 | $41.05 | 23,573 | D | — | — | |
| 4 | Common | Common Shares | 2024-11-22 | M | A | 3,086 | $13.48 | 26,659 | D | — | — | |
| 5 | Common | Common Shares | 2024-11-22 | F | D | 1,046 | $39.80 | 25,613 | D | — | — | (F1) Represents the closing price of the Company's common shares on November 21, 2024 for purposes of net settlement calculations. |
| 6 | Common | Common Shares | 2024-11-22 | S | D | 2,851 | $41.11 | 23,573 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2024-11-22 | M | D | 3,500 | $0.00 | 0 | D | $7.38 · — to 2026-06-01 | 3,500 Common Shares | (F3) The shares subject to the option are fully vested and exercisable. |
| 8 | Derivative | Stock Option (Right to Buy) | 2024-11-22 | M | D | 3,086 | $0.00 | 0 | D | $13.48 · — to 2025-05-03 | 3,086 Common Shares | (F3) The shares subject to the option are fully vested and exercisable. |